Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0L7AS
|
||||
Former ID |
DNC011151
|
||||
Drug Name |
NABILONE
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Insomnia [ICD9: 307.41, 307.42, 327.0, 780.51, 780.52; ICD10:F51.0, G47.0] | Approved | [551871] | ||
Structure |
Download2D MOL |
||||
Formula |
C24H36O3
|
||||
Canonical SMILES |
CCCCCCC(C)(C)C1=CC2=C(C3CC(=O)CCC3C(O2)(C)C)C(=C1)O
|
||||
InChI |
1S/C24H36O3/c1-6-7-8-9-12-23(2,3)16-13-20(26)22-18-15-17(25)10-11-19(18)24(4,5)27-21(22)14-16/h13-14,18-19,26H,6-12,15H2,1-5H3/t18-,19-/m1/s1
|
||||
InChIKey |
GECBBEABIDMGGL-RTBURBONSA-N
|
||||
CAS Number |
CAS 51022-71-0
|
||||
PubChem Compound ID | |||||
SuperDrug ATC ID |
A04AD11
|
||||
Target and Pathway | |||||
Target(s) | Cannabinoid receptor 2 | Target Info | Inhibitor | [531196] | |
Cannabinoid receptor 1 | Target Info | Inhibitor | [531196] | ||
PANTHER Pathway | Endogenous cannabinoid signaling | ||||
Pathway Interaction Database | N-cadherin signaling events | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.